Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05826054
PHASE1

Montbretin Clinical Trial in Healthy Volunteers and Type 2 Diabetics

Sponsor: Robert Petrella

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to test the investigational product, Montbretin A (MbA) in either individuals with type 2 diabetes (T2D) or healthy participants. The main questions it aims to answer are: * Safety of MbA * Whether MbA has less side effects in comparison to other medications used to treat T2D Participants will: * Be given MbA at increasing amounts (10 mg to 300 mg) over a two-week treatment period, along with standardized meal; * Undergo testing, including blood draws, blood sugar checks, electrocardiogram (ECG) and questionnaires.

Official title: Phase 1 Dose Escalating Study for Montbretin a

Key Details

Gender

All

Age Range

19 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2023-12-01

Completion Date

2025-02

Last Updated

2024-10-15

Healthy Volunteers

Yes

Conditions

Interventions

DIETARY_SUPPLEMENT

Montbretin A

The investigational product is 95% pure montbretin A (MbA), a glycosylated acyl-flavonol isolated from the corms (bulbs) of the Crocosmia plant through hot water extraction. It is a potent and specific inhibitor of human pancreatic amylase (HPA).

Locations (1)

VCHRI Clinical Research Unit

Vancouver, British Columbia, Canada